UPC Analytics
ENDE
Overview · Filed: Dec 4, 2023

UPC_CFI_463/2023

METHOD AND PRODUCT FOR LOCALISED OR SPATIAL DETECTION OF NUCLEIC ACID IN A TISSUE SAMPLE

Provisional measuresProvisional MeasuresDusseldorf LDProvisional measuresCase Closed
OverviewDecisionsReasoningCitationsDocumentsTimeline
Parties

Claimants

  • 10x Genomics, Inc.
Reps: Tilman Müller-Stoy (Bardehle Pagenberg); Martin Drews (Bardehle Pagenberg); Axel Berger (Bardehle Pagenberg)

Respondents

  • Curio Bioscience Inc.
Reps: Agathe Michel-De Cazotte; Cameron Marschall
Judges
  • Ronny Thomas
  • Berenice Thom
  • Andras Kupecz
  • Martin Schmidt
Patents
  • EP2697391
  • EP 2 697 391
CPC codes: C12Q1/6827, C12Q1/6841, C12Q1/6837, C12Q1/6853, G01N1/30, G16B30/00, C12Q1/6816, C12N15/11, G16B50/20, C12Q1/6844, C12Q1/6876, G16B50/30…

Sector: Biotechnology

Outcome
PI granted
Filed: Dec 4, 2023
First decided: Jan 29, 2024
Last decision: Feb 14, 2024
Language: English

The Düsseldorf Local Division granted a preliminary injunction against Curio Bioscience Inc. prohibiting it from offering, marketing, using, importing or storing arrays for spatially localised nucleic acid detection in Germany, France and Sweden, finding prima facie infringement of EP 2 697 391 B1 (owned by 10x Genomics). Both parties were ordered to pay each other interim costs of EUR 100,000. The injunction was conditional on 10x Genomics providing security of EUR 2,000,000. 10x Genomics' application for security for costs from the defendant was rejected.

Open on UPC Registry